TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
NA

Nano Labs Ltd

Technology · Semiconductors · listed since 2022

2.20$ -5.5% vs. previous close Closing price · As of: Sep 17, 2026
🔔 Watch stock
Add to watchlist

Assessment

Our Rating

A journalistic assessment by our editorial team at the time of the deep dive — it rates the company, not the entry point. Not investment advice and not a solicitation to buy or sell.

Substance risk

We found at least one documented issue that threatens the company itself — regardless of how the stock is currently valued.

Why this colour

Red, because two of the hard substance findings are documented rather than merely suspected. First, persistently negative operating cash flow despite reported profit: in 2023, 2024 and 2025 operating activities used RMB 133.5 million, RMB 139.3 million and RMB 108.3 million — including in 2025, the year of the reported RMB 125.9 million profit. In its "Liquidity" section the annual report itself ties continuation as a going concern to management executing its business plan and "continuing to gain support from outside sources of financing". Second, cash runway: at June 30, 2026 cash stood at RMB 9.0 million ($1.3 million), while cash operating costs for selling, administration and development in the preceding half-year alone came to RMB 35.4 million — that is not two months of cover, let alone four quarters. Add dependence on a single counterparty on the revenue side: 59.0 percent of 2025 revenue from one customer. Explicitly not relevant to the rating are the points one might expect here: that the share looks optically cheap at a price-to-book ratio of about 0.93, that it swung between $1.58 and $6.10 over twelve months, that the free float is narrow and short interest high. Those are price and trading arguments; they neither justify red nor rule out green. Fairness requires the other side: auditor MaloneBailey LLP issued the 2025 opinion without a going-concern emphasis, equity is clearly positive at RMB 400.2 million, the equity ratio stood at roughly 52 percent on June 30, 2026, and the crypto reserve is a liquid asset that can be sold. Yellow would come back into view once a full reporting period shows positive operating cash flow and cash covers a year of running costs — without selling reserve assets. The decision is yours.

What the thesis turns on

Assessment: Opportunities & Risks

Nano Labs runs three signs above the same door: chip designer, crypto treasury company and, since March 2026, supplier of AI agent hardware. Its filings with the U.S. securities regulator, the SEC, show what stands behind them: RMB 27.0 million of revenue in 2025 and RMB 2.8 million in the first half of 2026, both at a gross loss; a bottom line that tracks the BNB price (2025: +RMB 125.9 million; first half of 2026: −RMB 316.7 million); three consecutive years of cash draining out of operations and being replaced by the capital markets; and, at June 30, 2026, $1.3 million of cash against $51.5 million of liabilities. Against that stand real patents, a balance sheet that is not over-indebted and a liquid crypto reserve. Not investment advice.

Operating business

Revenue fell three years running from RMB 78.3 million (2023) through RMB 40.6 million (2024) to RMB 27.0 million (2025), and to RMB 2.8 million in the first half of 2026. In both most recently reported periods, cost of revenues exceeded revenue — a gross loss of RMB 39.8 million in 2025 and RMB 5.8 million in the first half of 2026. Research spending fell from RMB 88.6 million to RMB 8.1 million.

Earnings quality

The reported result measures the BNB price, not the business: in 2025 the change in fair value of cryptocurrency added RMB 178.6 million to net income of RMB 125.9 million; in the first half of 2026 the same line cost RMB 250.5 million and produced a loss of RMB 316.7 million. On top sit RMB 41.7 million of derivatives from decumulator contracts.

Liquidity & funding

At June 30, 2026 cash stood at RMB 9.0 million ($1.3 million) against RMB 35.4 million of cash operating costs in the preceding half-year alone and RMB 351.1 million of liabilities. Operating cash flow was negative throughout 2023 to 2025 (RMB −133.5 / −139.3 / −108.3 million); the capital markets filled the gap (RMB +199.5 / +376.0 / +382.4 million).

Dependencies

A single customer accounted for 59.0 percent of 2025 revenue and the top five for 84.0 percent — up from 13.0 percent and 53.0 percent in 2024. At the same time more than half of total assets (RMB 393.4 million of RMB 736.7 million at June 30, 2026) hangs on the price of one cryptocurrency, part of it pledged and part of it levered through derivatives.

Balance-sheet substance & valuation

The balance sheet is not over-indebted: RMB 736.7 million of total assets against RMB 351.1 million of liabilities, an equity ratio of roughly 52 percent; the share trades slightly below reported book value at a price-to-book ratio of about 0.93 (as of September 11, 2026). That book value, however, is mostly cryptocurrency, which lost roughly half its value in the last reported half-year.

Shareholder structure

Class B shares carry 50 votes each: at the time of the annual report, directors and executive officers held 34.9 percent of the shares and 90.7 percent of the votes. Authorized capital covers 1,097,141,091 Class A shares against 20,712,924 issued; the weighted average share count rose from 5.9 million (2023) to 22.7 million (first half of 2026) despite a 20-to-1 consolidation.

Worth Noting

Nano Labs reached our research list through market observation rather than a quality filter: a 52-week range of $1.58 to $6.10, beta 3.47, short interest at 9.7 percent of a free float of roughly 8.4 million shares, interest coverage of minus 6.28 and a Piotroski score of 5 out of 9 (data as of September 11, 2026). No Altman Z-score and no net current asset value, because the accounts are kept in yuan against a dollar listing.

Recency: the most recent periodic report is the annual report on Form 20-F for 2025, filed April 13, 2026. As a foreign private issuer, Nano Labs files no quarterly report (Form 10-Q); the latest figures come from the Form 6-K furnished August 28, 2026 (six months to June 30, 2026). All four 6-K reports after April 13, 2026 were reviewed, along with eight insider reports (Form 4) and two Form 144 notices that do not change the picture.

Confusion risk and currency: the ticker "NA" denotes other companies on other exchanges; this analysis covers only Nano Labs Ltd with SEC file number CIK 0001872302. The accounts are prepared under U.S. GAAP in Chinese yuan while the share trades in U.S. dollars; dollar figures in this article come from the company's own conversions (RMB 7.0288 per dollar at December 31, 2025; RMB 6.8109 at June 30, 2026).

Stock Watch

This analysis is as of September 18, 2026. Stock Watch will tell you what's changed at NA since then.

Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.

Price history

Chart

Interactive price chart (TradingView).

52-week range: 1.60 $ to 5.90 $ · Last price: 2.20 $ (As of: September 17, 2026)

Key figures

Key figures at a glance

Every figure we hold for this stock, grouped by topic. The question mark next to a label explains what the number means.

Basics

Market Cap ?The value of the entire company on the market: share price times total shares outstanding. 0.1$B
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 20m
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 41.4%
Beta ?Volatility versus the overall market: 1 = moves like the market, 2 = twice as much, under 1 = calmer than the market. 3.5

Performance

Perf. 1M ?Price performance over the last month. 37.00%
Perf. 3M ?Price performance over the last 3 months. 33.30%
Perf. 6M ?Price performance over the last 6 months. -15.90%
YTD Performance (%) ?Price performance since the start of the year (Year to Date). -21.27%
52-Week-High Distance ?How far the price sits below its highest point over the last 52 weeks. 0% means the stock is at its year high. -58.0%
Perf. 1Y ?Price performance over the last 12 months. -53.09%
Perf. 3Y ?Price performance over the last 3 years. -79.04%
Perf. Since Inception ?Price performance since the first available trading day (07/13/2022) — with a complete history, that is since the IPO. -97.33%

Technical Indicators

MA 38 Days ?Moving average of the last 38 trading days: the smoothed price path. A price above it signals short-term strength. 2.00$
MA 50 Days ?Moving average of the last 50 trading days — the most widely watched medium-term trend line. 2.00$
MA 200 Days ?Moving average of the last 200 trading days — the dividing line between a long-term uptrend and downtrend. 2.60$
RSI (14) ?Relative Strength Index over 14 days, scale 0 to 100: above 70 counts as overbought, below 30 as oversold. A hint on timing, not a verdict on the company. 60.4
Volatility 30 Days ?Price swings over the last 30 trading days, annualized. The higher the value, the more the price fluctuates. 58.6%
Volatility 250 Days ?Price swings over the last 250 trading days (roughly one market year), annualized. 88.6%

Calculated from the price history · as of 09/17/2026

Valuation

P/E ?Price-to-earnings ratio: how many years of profit does the stock cost? The lower, the cheaper the valuation. No earnings means no P/E.
Forward P/E ?P/E based on expected earnings for the next 12 months instead of past earnings — analysts' bet on the future. 0.0
PEG ?P/E divided by expected earnings growth: puts valuation in relation to growth. Around 1 is considered fair, well above that is pricey.
P/B ?Price-to-book ratio: market value relative to book equity. 0.8
P/S ?Price-to-sales ratio: market value divided by annual sales. Important for companies that aren't (yet) profitable. 13.4
EV/EBITDA ?Enterprise value including debt (EV) relative to operating profit before depreciation and amortization (EBITDA) — more comparable than P/E because debt counts too. Extreme values arise when EBITDA is near zero. 1.3
Price/FCF ?Market value divided by free cash flow: how many years of freely available cash does the stock cost? More honest than P/E because cash flow is harder to dress up.

Profitability

Gross Margin ?Gross margin: what's left of sales after only direct production costs are deducted — the product's pricing power. -10.7%
EBIT Margin ?EBIT margin: operating profit as a percentage of sales — the earning power of the core business before interest and taxes. -1,483.9%
Net Margin ?Net margin: what's left of sales as profit after ALL costs, interest, and taxes. 0.0%
Return on Equity ?Return on equity: how much profit does the company generate per year on shareholders' equity? -35.6%
Return on Assets ?Return on assets: how much profit the company generates from its total assets (equity and debt combined). -4.4%

Balance Sheet & Safety

Equity Ratio ?Equity ratio: equity as a share of total assets. The higher, the more resilient the balance sheet. 66.8%
Debt/Equity ?Leverage ratio: financial debt divided by equity. Under 1 is generally seen as solid; negative values mean negative equity. 0.3
Altman Z″ ?Edward Altman's bankruptcy early-warning score. We use the Z″ variant, built from four balance-sheet ratios — it is designed for service companies and non-manufacturers and uses book value instead of market value. On that scale: below 1.1 = danger zone, 2.6 and up = safe zone, in between a grey area. Because the classic Altman Z is calculated differently, the two numbers are not directly comparable. The formula does not fit banks, insurers, or real-estate stocks.
Piotroski ?Balance-sheet health check by Joseph Piotroski: 9 yes/no criteria on profit, cash flow, leverage, and efficiency. 7+ is very solid, under 3 is a red flag. 5 out of 9

Growth

Sales Growth Last Quarter ?Sales growth in the most recently reported quarter versus the same quarter a year ago (YoY). -66.50%
EPS Growth Last Quarter ?Growth in earnings per share in the most recently reported quarter versus the same quarter a year ago (YoY). 0.00%
Sales Growth (Year) ?Sales growth in the last fiscal year versus the year before. -33.47%
Forward Sales Growth ?Sales growth analysts expect over the next 12 months — an estimate, not a guarantee.
Forward EPS Growth ?Earnings-per-share growth analysts expect over the next 12 months — an estimate, not a guarantee.

Dividend

This stock currently pays no dividend.

Quality & Screener

Stage ?Weinstein phases 1 through 4: 1 = basing, 2 = uptrend (the only buy phase), 3 = topping, 4 = downtrend. Measured against the 30-week line.
RS Rating ?Relative strength from 1 to 99: an RS of 95 means the stock has outperformed 95% of all stocks.
EPS Rating ?Earnings growth rating from 1 to 99 versus all stocks — high values mean above-average earnings growth.
Fundamental Rating ?Our own Fundamental Rating: 0 to 100 points with an A+ to F grade. 50 points is the average across the universe, 100 the best possible score. It scores growth, earnings surprises, analyst estimates, margins, cash flow, and balance-sheet safety — every stock percentile-ranked against all others. Grades: A+ from 95, A from 75, B from 55, C from 45, D from 25, E from 5, F below. D (42 out of 100)

Comparison

Industry comparison

The stock alongside the largest companies in the same group. The median row is the middle value of the companies shown above — not of the whole industry.

Industry: Semiconductors

Industry comparison
Company Market cap ($B) P/E EV/EBITDA Gross Margin % EBIT Margin % Sales Growth (Year) % Perf. 1Y %
Nano Labs Ltd NA 0.1 1.3 -10.7 -1,483.9 -33.5 -53.1
NVIDIA Corporation NVDA 5,540.3 30.4 22.4 74.7 65.6 65.5 29.1
Broadcom Inc AVGO 1,652.3 55.2 33.7 75.5 49.0 23.9 1.1
Micron Technology Inc MU 1,269.8 20.7 15.8 72.6 80.4 48.9 512.0
Advanced Micro Devices Inc AMD 943.2 177.7 77.8 55.7 14.4 34.3 242.5
Intel Corporation INTC 546.8 145.4 38.9 6.9 -0.5 337.0
Arm Holdings plc ARM 282.9 267.6 221.2 97.5 7.6 22.8 58.6
Texas Instruments Incorporated TXN 234.9 39.7 26.1 58.3 37.8 13.1 46.9
Marvell Technology Group Ltd MRVL 232.5 79.7 45.0 52.2 14.5 42.1 239.9
Median of companies shown 546.8 55.2 33.7 58.3 14.5 23.9 58.6

Based on the most recently reported figures. Only stocks from the same trading venue are lined up, so the market caps are counted in one currency. Compare in a chart →

Fiscal years

Annual Figures

Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.

Revenue, operating income and net income per fiscal year CNY m

Revenue Operating income Net income

2019 · Operating income: -11 CNY m 2019 · Net income: -11 CNY m 2020 · Revenue: 2 CNY m 2020 · Operating income: -37 CNY m 2020 · Net income: -38 CNY m 2021 · Revenue: 39 CNY m 2021 · Operating income: -179 CNY m 2021 · Net income: -175 CNY m 2022 · Revenue: 983 CNY m 2022 · Operating income: 21 CNY m 2022 · Net income: 31 CNY m 2023 · Revenue: 78 CNY m 2023 · Operating income: -261 CNY m 2023 · Net income: -253 CNY m 2024 · Revenue: 41 CNY m 2024 · Operating income: -99 CNY m 2024 · Net income: -113 CNY m 2025 · Revenue: 27 CNY m 2025 · Operating income: -107 CNY m 2025 · Net income: 135 CNY m
2019202020212022202320242025
Annual Figures
Fiscal Year Revenue (CNY m) EBIT (CNY m) Net Income (CNY m) EPS (CNY) Operating Cash Flow (CNY m) Equity (CNY m) Total Assets (CNY m)
2019 -11 -11 -0.28 9 -11 22
2020 2 -37 -38 -0.73 -3 -49 61
2021 39 -179 -175 -3.37 72 -25 910
2022 983 21 31 0.58 -275 164 367
2023 78 -261 -253 -4.29 -133 -15 350
2024 41 -99 -113 -1.67 -139 231 616
2025 27 -107 135 5.74 -108 749 1,120

Quarters

Quarterly Figures

Each bar is one quarter, the last one is the most recent. Use the switch to step through the individual figures.

Revenue & Profit

Cash Flow

Balance Sheet

Margins

Per Share

Click the chart or tab into it, then use ← and → to step through the periods.

None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.

These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.

The figures could not be loaded right now.

Sales Per Quarter (CNY m)
2023: Q2 · 26.1 CNY m Q2 2023: Q3 · 13.0 CNY m Q3 2024: Q1 · 12.4 CNY m Q1 2024: Q2 · 12.4 CNY m Q2 2024: Q3 · 7.9 CNY m Q3 2025: Q1 · 4.1 CNY m Q1 2025: Q2 · 4.1 CNY m Q2 2025: Q3 · 9.4 CNY m Q3

Source: fundamental data

Quarterly Figures
Quarter EPS (Earnings Per Share) EPS YoY (%) Sales (CNY m) Sales YoY (%) Net Margin (%) OCF (CNY m) FCF (CNY m)
2023: Q2 26 -86.30 -257.00 -17 -60
2023: Q3 13 -97.80 -460.50 -49 -59
2024: Q1 12 -52.70 -231.30 -38 -55
2024: Q2 12 -52.70 -231.30 -38 -55
2024: Q3 8 -39.20 -352.90 -31 -33
2025: Q1 -6.00 4 -66.50 -85.20 -25 -26
2025: Q2 -0.43 4 -66.50 -85.20 -25 -26
2025: Q3 9 18.10 761.20 -29 -29

What Do These Terms Mean?

EPS (Earnings Per Share):
Quarterly profit divided by the total share count — how much of the profit works out to a single share.
YoY (Year over Year):
Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
Sales:
All revenue for the quarter, before any costs are deducted — the top line of the income statement.
Net Margin:
What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
OCF (Operating Cash Flow):
The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
FCF (Free Cash Flow):
Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.

Compare with other stocks →

Screening

Appears in These Scanners

This stock currently matches 4 of our scanner strategies — each hit links to the scanner.

Quality & Balance Sheet

Research

Risk & Weakness

Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. Scanners marked in red are red-flag signals (risk/short scanners) — appearing there is not a seal of approval. View all scanners

AI classification

AI Rating

Sells AI

Nano Labs verkauft seit März 2026 mit dem iPollo ClawPC A1 Mini eine eigene KI-Hardware-Produktlinie für das OpenClaw-Agentensystem; der Jahresbericht 20-F für 2025 führt sie im Geschäftsmodell-Kapitel als neues Geschäftsfeld, weist dafür aber noch keinen nennenswerten Umsatzbeitrag aus.

View the full file — quotes, sources, reviewed filings
„We launched the iPollo ClawPC A1 Mini in March 2026, a dedicated hardware solution designed to support the OpenClaw AI Agent System."

Wir haben im März 2026 den iPollo ClawPC A1 Mini auf den Markt gebracht, eine eigens entwickelte Hardware-Lösung zur Unterstützung des OpenClaw-KI-Agentensystems.

20-F · 2026-04-13 · View SEC filing

„The OpenClaw product line represents a new business initiative that involves the development of both hardware and software solutions for AI agent applications."

Die OpenClaw-Produktlinie ist eine neue Geschäftsinitiative, die die Entwicklung von Hardware- und Software-Lösungen für KI-Agenten-Anwendungen umfasst.

20-F · 2026-04-13 · View SEC filing

„The Parties intend to explore the potential establishment of AI data center infrastructure in North America, including evaluation of compute infrastructure requirements for agentic AI workloads, deployment architecture, security considerations, and cost structure and commercialization pathways."

Die Parteien beabsichtigen, den möglichen Aufbau einer KI-Rechenzentrums-Infrastruktur in Nordamerika zu prüfen, einschließlich der Bewertung des Rechenbedarfs für agentische KI-Lasten, der Einsatzarchitektur, der Sicherheitsfragen sowie der Kostenstruktur und der Wege zur Vermarktung.

6-K · 2026-04-24 · View SEC filing

Filings Reviewed: 20-F 2026-04-13 · 6-K 2026-08-31 · 6-K 2026-08-28 · 6-K 2026-08-05 · 6-K 2026-04-24 · 6-K 2026-03-30

Rated on September 13, 2026 · How the Rating Is Built

Growth

Growth Score

Ten checks against the annual reports — each one passed counts a point.

3 of 10 Weak growth
  • Revenue grows by more than 15% a year over three years -69.8%
  • More than 10% revenue growth is expected for the coming year no data
  • Share count grows by less than 3% a year -23.9%
  • Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") -434.5%
  • Gross margin at 40% or higher and without meaningful erosion -147.3%
  • Goodwill from acquisitions does not grow faster than revenue 0.0%
  • Net debt below twice EBITDA failed
  • Operating cash flow covers the profits of the last three years -151 m
  • Return on capital at 15% or higher, or up versus two years ago -11.7%
  • Insiders hold at least 10% or are net buyers 56.0%

A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail

Quality check

AAQS

2/10

The AAQS (AlleAktien Quality Score) checks 10 quality criteria on growth, profitability, and balance-sheet strength — per the methodology developed and published by AlleAktien, calculated by us from our own fundamental data. A stock counts as a quality stock from 9 out of 10 points. Where a company has a shorter listing history, we calculate over the fiscal years available (at least five).

  • Sales growth 10Y > 5% 66.2%
  • Exp. sales growth 3Y > 5%
  • EBIT growth 10Y > 5%
  • Exp. EBIT growth 3Y > 5%
  • Net debt < 4x EBIT
  • EBIT positive, 10Y straight 1
  • Max. EBIT decline < 50% 100.0%
  • Return on equity > 15% 19.3%
  • ROCE > 15% -11.7%
  • Expected return > 10%

View stocks with the full AAQS score · Read the methodology at AlleAktien

Source: fundamental data

Insiders

Insider Transactions

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.

Insider Transactions
Date Person Role Type Shares Price Value
Apr 20, 2026 Nan Hu Director Sell 4,092 2.71 11,089
Apr 17, 2026 Nan Hu Director Sell 1,633 2.86 4,670

View all insider transactions →

The company

About the Company

Nano Labs Ltd engages in the design and sale of fabless integrated circuit and product solutions in the People's Republic of China, Hong Kong, Singapore, the United States, and internationally. The company develops HTC chips and HPC chips. It offers Cuckoo 1.0, Cuckoo 2.0, and Cuckoo 3.0 which target the ASIC-resistant mining algorithms of cryptocurrencies, such as Ethereum Classic and Grin; and Darkbird 1.0 HPC chips. The company serves enterprises and individual buyers. Nano Labs Ltd was founded in 2019 and is headquartered in Hangzhou, the People's Republic of China.

Employees
67
Headquarters
Hangzhou, China
Address
China Yuangu Hanggang Tech Bldg, 310000 Hangzhou, China
Phone
86 571 8665 6957
Website
nano.cn
IPO Date
07/12/2022
ISIN
KYG6391Y1281
Stock Split
1:10 on 11/04/2024

Management

Management
Name Title Birth Year
Jianping Kong Chairman & CEO 1986
Bing Chen CFO & Senior VP 1969
Yang Can SVP of Nano bit HK Limited

Executives per the latest required filings; titles kept in their original language. Source: fundamental data.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?